Seeing the forest and the tree: TILs and PD-L1 as immune biomarkers
Peter Savas, Roberto Salgado, Sherene Loi
Topics & Concepts
Breast cancerClinical trialBiomarkerImmunotherapyMedicineCancerOncologyBiomarker discoveryImmune systemInternal medicineBioinformaticsImmunologyBiologyProteomicsBiochemistryGeneCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy research